Atlas Trials

A Novel Biomarker for Response and Prognosis of HBV-related Hepatocellular Carcinoma

Clinical trial NCT05752890 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05752890
Sponsor
National Taiwan University Hospital
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Hepatocellular CarcinomaHepatitis b VirusRadiotherapyBiomarker
Start date
2023-03-01
Primary completion
2031-01-31
Enrollment
95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.